C. Porter

发表

Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure.

J. Spertus, C. P. Green, C. Porter, 2000, Journal of the American College of Cardiology.

Beneficial hemodynamic effects of intravenous and oral diltiazem in severe congestive heart failure.

C. Porter, R. O'rourke, M. Starling, 1984, Journal of the American College of Cardiology.

Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial

M. Pfeffer, J. Rouleau, C. Porter, 2000, The Lancet.

Thromboxane A2-induced arrhythmias in the anesthetized rabbit.

C. Porter, M. Wacker, J. Orr, 2006, American journal of physiology. Heart and circulatory physiology.

Secular trends in cardiac transplant recipient and donor management in the United States, 1990 to 1994. A multi-institutional study. Cardiac Transplant Research Database Group.

C. Porter, L. Stevenson, L. Miller, 1996, Circulation.

Matching the heart donor and heart transplant recipient. Clues for successful expansion of the donor pool: a multivariable, multiinstitutional report. The Cardiac Transplant Research Database Group.

C. Porter, J. Farmer, R. Rodeheffer, 1994, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Differential effects of diltiazem and nitroprusside on left ventricular function in experimental chronic volume overload.

C. Porter, R. O'rourke, R. Walsh, 1983, Circulation.

Improved myocardial oxygen utilization by diltiazem in patients.

C. Porter, R. O'rourke, M. Kern, 1985, American heart journal.

Plasma atrial peptide concentration during acute changes in cardiac filling pressure induced by a contrast agent

C. Porter, P. G. Geer, K. Goetz, 1987, Clinical cardiology.

CALL FOR PAPERS Regulation of Cardiovascular Functions by Eicosanoids and Other Lipid Mediators Thromboxane A 2 -induced arrhythmias in the anesthetized rabbit

C. Porter, J. Stachura, M. Wacker, 2006 .

Omega-3 Fatty Acids in Cardiac Biopsies From Heart Transplantation Patients: Correlation With Erythrocytes and Response to Supplementation

C. Porter, S. Sands, W. Harris, 2004, Circulation.

Omega-3 Fatty Acids in Cardiac Biopsies From Heart Transplantation Patients Correlation With Erythrocytes and Response to Supplementation Transplantation

C. Porter, W. Harris, A. Magalski, 2004 .

Impact of Hormonal Therapies for Treatment of Hormone-Dependent Cancers (Breast and Prostate) on the Cardiovascular System: Effects and Modifications: A Scientific Statement From the American Heart Association.

K. F. Moseley, C. Porter, J. Plana, 2021, Circulation. Genomic and precision medicine.

Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study.

Sana M. Al-Khatib, Shantanu Sarkar, Christopher M. O’Connor, 2010, Journal of the American College of Cardiology.

Regional coronary vasoconstriction after combined beta-adrenergic and calcium channel blockade in patients with coronary artery disease.

C. Porter, R. O'rourke, M. Kern, 1985, Journal of the American College of Cardiology.

Who is most likely to enjoy long term survival after cardiac transplantation? Risk stratification in a 10 year multi-institutional experience.

C. Porter, L. Miller, C. White-Williams, 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Changes in Intrathoracic Fluid Index predict subsequent adverse events: Results of the Multi-site Program to Access and Review Trending INformation and Evaluate CoRrelation to Symptoms in Patients with Heart Failure (PARTNERS HF) Trial

C. O'connor, C. Porter, D. Whellan, 2008 .

Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure.

J. Spertus, C. Porter, D. Bresnahan, 2000, Journal of the American College of Cardiology.